Search results

Order by most recent / most popular / relevance

Results: 1-10 of 1,399

BRCA1 & BRCA2 genetic testing what do you get for $3000?

Phillips Ormonde Fitzpatrick
-
Australia
-
May 22 2013

With the recent media coverage of Angelina Jolie's decision to have a preventative double mastectomy following genetic testing for BRCA mutations and

A patent landscape analysis: iPSCs

Foley & Lardner LLP
-
USA
-
May 16 2013

There are several emerging technology clusters in the induced pluripotent stem cell (iPSC) space. Simon Elliot and I conducted a patent landscape

Supreme Court declines to hear Eli Lilly’s “promise of the patent” appeal

Bereskin & Parr LLP
-
Canada
-
May 16 2013

The Supreme Court of Canada denied leave to appeal today from the Federal Court of Appeal ("FCA") decision in Eli Lilly Canada Inc v Novopharm Ltd

What's in a name? Eli Lilly's olanzapine patent deemed valid on all grounds

Davies Collison Cave
-
Australia
-
May 16 2013

The Federal Court has upheld the validity of Eli Lilly’s Australian patent covering anti-psychotic drug olanzapine in a recent revocation action

Advocate General confirms Dutch Court of Appeal's Cipralex decision

NLO (Nederlandsch Octrooibureau)
-
Netherlands
-
May 15 2013

Over the past few years Lundbeck's patents protecting its blockbuster drug Cipralex have been subject to invalidation actions around the world

AOD-9604: patents, peptides, performance and.cellulite?

Phillips Ormonde Fitzpatrick
-
Australia
-
May 14 2013

Australia is no stranger to sporting scandals. Cricket's "John the bookmaker" affair, horse racing's "Fine Cotton" scandal and any number of player

What goes upmust come down: Viagra patent invalidated by Canadian Supreme Court

Drinker Biddle & Reath LLP
-
Canada
-
May 13 2013

Pfizer and Teva have been fighting a legal battle over Pfizer's patent for Viagra in Canada. The first shot was fired when Novopharm Limited, now

ALJ Essex denies motion for leave to supplement notice of prior art in Certain Reduced Folate Nutraceutical Products (337-TA-857)

Oblon Spivak McClelland Maier & Neustadt LLP
-
USA
-
May 10 2013

On May 8, 2013, ALJ Theodore R. Essex issued Order No. 10 denying Respondents Macoven Pharmaceuticals, LLC and Viva Pharmaceuticals, Inc.'s

EU-India free trade agreement: pharmaceutical IP protection remains an issue

King & Spalding LLP
-
European Union, India
-
May 10 2013

The Indian commerce and industry minister recently submitted a letter to the Indian Parliament to update it on the progress in negotiations with the

IPAB upholds the first compulsory license granted to generic drug company

Nishith Desai Associates
-
India
-
May 10 2013

In March last year, the Controller General of Patents ("Controller") created history with a landmark judgment granting the first ever Compulsory

next >

Search results

BRCA1 & BRCA2 genetic testing what do you get for $3000?

A patent landscape analysis: iPSCs

Supreme Court declines to hear Eli Lilly’s “promise of the patent” appeal

What's in a name? Eli Lilly's olanzapine patent deemed valid on all grounds

Advocate General confirms Dutch Court of Appeal's Cipralex decision

AOD-9604: patents, peptides, performance and.cellulite?

What goes upmust come down: Viagra patent invalidated by Canadian Supreme Court

ALJ Essex denies motion for leave to supplement notice of prior art in Certain Reduced Folate Nutraceutical Products (337-TA-857)

EU-India free trade agreement: pharmaceutical IP protection remains an issue

IPAB upholds the first compulsory license granted to generic drug company

Current Search

Suggested Facets

Author

Firm Name

Jurisdiction

Workarea